Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized study of RDEA3170 vs placebo and allopurinol in Japanese patients with gout or asymptomatic hyperuricemia
jRCT2080222512Phase 2
- Sponsor
- AstraZeneca
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of verinurad in gout and hyperuricemia (5 arms), sponsored by AstraZeneca.
02
Drugs
verinurad
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on jRCT2080222512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222512.